Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
D.TurrigianoG
Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Table of Contents How FOXO4-DRI Works (Relevant to Timing) Week 1: Initial Administration Weeks 2-3: Early Clearance Phase Weeks 4-6: Post-Course Assessment Months 2-6: Rest Period and Potential Continued Effects Subsequent Courses Factors That Affect Results Timeline by Potential Benefit When to Assess the Protocol Related Reading References How FOXO4-DRI Works (Relevant to Timing) Understanding the mechanism explains why FOXO4-DRI results follow a different timeline than most peptides
After initial instruction from your provider, most patients self-administer at home
US$ 28.04
US$ 20.65
US$ 21.06
US$ 26.40
US$ 29.65
US$ 22.86
US$ 23.58
